SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
60
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in GreenSky, Inc. of Class Action Lawsuit and Upcoming Deadline – GSKY

NEW YORK, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against, GreenSky, Inc. (“GreenSky” or the “Company”) (NASDAQ: GSKY) and certain of its officers.  The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-00100, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise, acquired GreenSky Class A common stock pursuant or traceable to the Company’s false and misleading registration statement and prospectus, who were damaged thereby, and who seek to pursue remedies under the Securities Act of 1933 (“Securities Act”).

If you are a shareholder who purchased GreenSky Class A common stock pursuant or traceable to the Company’s registration statement and prospectus, you have until January 28, 2019, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com .  To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here to join this class action]

GreenSky is a financial technology company in Atlanta, Georgia, and runs an online platform that allows creditors to process loan applications at the point of sale.  GreenSky’s platform is actively used by over 10,000 businesses. Consumers use GreenSky’s mobile app to make purchases from those listed business by applying for on-the-spot financing via the app.

GreenSky’s two principal sources of revenue are: (i) “transaction fees” the Company receives upfront when a consumer secures a loan through the GreenSky platform and makes a purchase; and (ii) recurring fees generated from banks over the lives of loans it facilitates. Transaction fees are critical to GreenSky’s business. For example, transaction fees accounted for 87% of the Company’s revenue in 2017. These transaction fees vary per the particular agreement between GreenSky and a merchant.

On April 27, 2018, GreenSky filed a registration statement. Then, on May 25, 2018, GreenSky filed a prospectus for its upcoming initial public offering (“IPO”). GreenSky’s registration statement and prospectus are referred to herein as the “Offering Documents.”

On May 29, 2018, GreenSky’s IPO closed and the Company sold 43.7 million shares of Class A common stock at $23.00 per share in its IPO, for gross proceeds of over $1 billion.

The complaint alleges that The Offering Documents were negligently prepared and, as a result, contained untrue statements of material facts or omitted to state other facts necessary to make the statements made not misleading, and were not prepared in accordance with the rules and regulations governing their preparation as the Offering Documents failed to disclose: (i) that GreenSky was transitioning away from the solar power market in favor of the elective healthcare market; (ii) foreseeable negative effects on GreenSky’s profits because of significant differences in transaction fees GreenSky charged to different classes of merchants; (iii) the primacy of the merchant mix as a driver of GreenSky’s transaction-fee revenue; (iv) the ongoing deterioration in GreenSky’s transaction-fee revenue, while touting GreenSky’s growth and financial performance; (v) the negative impacts of GreenSky’s changing merchant mix on EBITDA; (vi) the markedly lower transaction fees GreenSky charges to healthcare companies; and (vii) as a result of the foregoing, GreenSky’s Offering Documents were materially false and misleading at all relevant times.

On August 7, 2018, GreenSky issued a release announcing its financial results for the second quarter of 2018. The release indicated that the Company’s transaction-fee rate was approximately 53 basis points below the rate achieved in the second quarter of 2017.  In an earnings call, Defendant Zalik acknowledged that this rapid reduction was attributable to the transition away from solar panel merchants and toward elective healthcare companies.

On November 6, 2018, GreenSky lowered its full-year 2018 transaction volume guidance from between $5.1 and $5.3 billion to between $4.9 and $5.1 billion and lowered its full-year 2018 Adjusted EBITDA guidance from between $192 and $199 million to between $165 and $175 million.  GreenSky attributed the reduction to a general labor shortage and unfavorable shifts in its loan mix. 

Following these disclosures, GreenSky’s stock price closed at $9.28 per share, a decline of $13.72, or approximately 60%, from the IPO price of $23.00 per share.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com 888-476-6529 ext. 9980

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading

Top 5 Most Recently Viewed Articles

Lesaka Technologies Set to Review Year-End Performance Soon

Updated Category News Views 190

Lesaka Technologies to Host Year-End Results Webcast Lesaka Technologies, Inc. (NASDAQ: LSAK) is gearing up to release its fourth quarter and year-end results for 2025, an event anticipated by investors and analysts alike. This significant announcement will come shortly after the U.S. market closes on September 10, 2025. On the following day, the company's management will...

Continue Reading
RYVYL Inc. Reports Strong Revenue Growth in Q3 2024

Updated Category News Views 149

RYVYL Inc. Reports Strong Revenue Growth in Q3 2024 RYVYL Inc. (NASDAQ: RVYL), a pioneer in payment transaction solutions utilizing proprietary blockchain technology, has showcased its performance for the third quarter ended September 30, 2024. The latest results indicate exciting upward trends and milestones for the company. Third Quarter Highlights and Growth Drivers...

Continue Reading
NASA Selects Metis Technology Solutions for Key Contract Role

Updated Category News Views 171

Navigating New Frontiers in Aerospace Contracts NASA, the renowned leader in space research and exploration, recently made headlines by selecting Metis Technology Solutions Inc. to spearhead engineering and simulation services. This landmark decision signals a commitment to advancing aerospace research and development across various vital projects. Insights Into the ARTS...

Continue Reading
Investigation into Data Breach at True World Holdings

Updated Category News Views 150

Investigation into Data Breach at True World Holdings In a troubling development, Federman & Sherwood has launched an investigation concerning a data breach affecting True World Holdings LLC. This seafood distributor, recognized for its vast network of supplying seafood to hotels and restaurants, has encountered serious cybersecurity issues that put personal information...

Continue Reading
Kevin Fuller Joins Nature's Sunshine as Global Marketing Leader

Updated Category News Views 211

Kevin Fuller Takes on the Role of Global Chief Marketing Officer Nature’s Sunshine Products, Inc. (NASDAQ: NATR), known for its top-tier herbal and nutritional supplements, has initiated a significant change with the appointment of Kevin Fuller as its Global Chief Marketing Officer. This vital decision underscores the company's commitment to expand its presence and...

Continue Reading